Exelixis Inc at JPMorgan Healthcare Conference (Virtual) Transcript
All right. Thank you, and welcome back to the 40th Annual JPMorgan Healthcare Conference. My name is Matt Bannon. I'm a healthcare banker here at JPM. I'm really excited to introduce our next presenting company, Exelixis. And on behalf of Exelixis, we have President and CEO, Michael Morrissey. Mike, I'll turn it over to you.
Fantastic and thanks, Matthew, and thanks to the entire JPMorgan team for the invite and the opportunity to tell you about Exelixis and how we're looking at 2022 and beyond. I was just talking to Chris Senner, our CFO, about doing this live back in 2020, and that seems like a lifetime ago and I'm really hopeful that we'll be doing this live again in 2023.
So -- but here we are, we're virtual. We're in Alameda. And I'll walk you through the deck that we've got and be happy to answer some questions. First slide, the title, I think, to a certain degree, says it all. We are really in the process of moving to become a global multiproduct oncology company. We
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
